Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lone Tree

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

10107 RidgeGate Parkway, Suite 200
Lone Tree, CO 80124
P: (303) 925-0700

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Boulder

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

4715 Arapahoe Avenue
Boulder, CO 80303
P: (303) 385-2068

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

6031 East Woodmen Road, Suite 200
Colorado Springs, CO 80923
P: (719) 577-2555

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Colorado Springs

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

2312 N Nevada Ave, Suite 400
Colorado Springs, CO 80907
P: (719) 577-2555

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

4700 E Hale Parkway, Suite 400
Denver, CO 80220
P: (303) 321-0302

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Denver

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

1800 N Williams St, Suite 200
Denver, CO 80218
P: (303) 388-4876

More Details View Practice Page

Gall Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Aurora

A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination with Paclitaxel versus Paclitaxel Alone in Adult Patients with Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers who have received One Prior Systemic Chemotherapy Regimen (CTX-009-002)

  • Details

ClinicalTrials.gov ID: NCT05506943
Diagnosis Type: Gall Bladder Cancer
USOR Number: 22147

  • Practice Details

1700 S Potomac Street
Aurora, CO 80012
P: (303) 418-7659

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Thornton

Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of BI 907828 for treatment of patients with locally advanced/ metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours. (1403-0011)

  • Details

ClinicalTrials.gov ID: NCT05512377
Diagnosis Type: Urothelial Cancer
USOR Number: 22123

  • Practice Details

8820 Huron St
Thornton, CO 80260
P: (303) 386-7622

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of BI 907828 for treatment of patients with locally advanced/ metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours. (1403-0011)

  • Details

ClinicalTrials.gov ID: NCT05512377
Diagnosis Type: Urothelial Cancer
USOR Number: 22123

  • Practice Details

22 W Dry Creek Circle
Littleton, CO 80120
P: (303) 730-4700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lone Tree

Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of BI 907828 for treatment of patients with locally advanced/ metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours. (1403-0011)

  • Details

ClinicalTrials.gov ID: NCT05512377
Diagnosis Type: Urothelial Cancer
USOR Number: 22123

  • Practice Details

10107 RidgeGate Parkway, Suite 200
Lone Tree, CO 80124
P: (303) 925-0700

More Details View Practice Page
1 5 6 7 8 9 40